Sign up Australia
Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals tops the ASX Most Traded on back of medical cannabis revenues

The company has traded over $5 million worth of stock in the first 45 minutes.
MGC Pharmaceuticals tops the ASX Most Traded on back of medical cannabis revenues
The most active stocks in morning trade

MGC Pharmaceuticals Ltd (ASX:MXC) has traded 88 million shares in the first 45 minutes of trade, with the stock jumping 71% to $0.065.

Driving the investor momentum is details emerging that the company has signed a binding terms and conditions agreement with Varm Cosmo Inc. for its MGC Derma division to supply five of its cannabidiol cosmetic products in bulk form, to be sold to consumers as part of Varm Cosmo’s cosmetics range.

With a minimum agreed purchase quantity of 15,000 kilograms per month, the expected deal will generate circa $40 million in annual revenue for MGC Derma.

The MGC Derma division is a 51:49 joint venture with Dr. M. Burstein Ltd, of which MGC Pharmaceuticals owns 51% and holds management control.

Company Name Code Last Change Volume
MGC Pharmaceuticals Ltd MXC $0.065 71.05% 88,084,263
Australian Mines Ltd AUZ $0.053 -13.12% 65,137,946
Magnum Gas & Power Ltd MPE $0.002 100% 40,931,125
Range Resources Ltd RRS $0.002 -33.33% 38,614,460
Reffind Ltd RFN $0.016 14.29% 33,234,044
Atlas Iron Ltd AGO $0.018 5.88% 28,158,015
AVZ Minerals Ltd AVZ $0.180 12.50% 24,951,416
Lakes Oil NL LKO $0.002 0% 23,430,499
Laneway Resources Ltd LNY $0.003 0% 19,706,583
Thred Ltd THD $0.014 16.67 19,401,095

 

View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

Lego ball
September 14 2018
The company's latest push is a joint venture agreement with US-based entertainment firm Three Six Zero, which has steered the careers of pop stars such as Calvin Harris
Apollo 11
February 22 2018
Immersive VR, a technology company focused on the education space, was the first company Sure backed
Media junkie
February 14 2018
In modern parlance, Ebiquity is making a pivot towards becoming the "world's leading tech-enabled marketing and media analytics consultancy"

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use